While research remains ongoing, investigators are studying how Retatrutide may affect body weight, appetite regulation, glucose metabolism, and overall metabolic health
I see myself as the pioneering zerothe inaugural integration of a human with technology, aiming for an autonomous growth trajectory
These include model phenotyping studies and the characterization of several MASH-targeted drug classes, such as GLP1R agonists (e.g., semaglutide), THR- receptor agonists (e.g., resmetirom), PPAR agonists (e.g., lanifibranor), FGF21 analogues (e.g., efruxifermin), as well as various long-acting dual GLP1R-GIPR agonists (e.g., tirzepatide) and GLP1R-GCGR agonists (e.g., survodutide)
Goodman T, Hajihosseini MK